GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis
- 2 December 2024
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 44 (12) , 5425-5433
Abstract
Background/Aim: This study examined the role of GNAO1 as a potential tumor suppressor gene in colorectal cancer (CRC). Materials and Methods: RNA-seq data analysis revealed a significant GNAO1 down-regulation in colon cancer tissues compared to normal colon tissues. Results: GNAO1 over-expression in CRC cell lines inhibited cell proliferation, migration, and tumor formation both in vitro and in vivo. This study suggests that GNAO1 exerts its tumor-suppressive effects by inhibiting the mTOR/S6K signaling pathway. The observed correlation between GNAO1 expression and cancer progression highlights its potential as a prognostic marker and therapeutic target in CRC. Conclusion: This study provides a foundation for further exploration of the molecular mechanisms by which GNAO1 influences CRC pathogenesis, with significant implications for its application in clinical settings.Keywords
This publication has 17 references indexed in Scilit:
- The S6K protein family in health and diseaseLife Sciences, 2015
- The down-regulation of GNAO1 and its promoting role in hepatocellular carcinomaBioscience Reports, 2013
- De Novo Mutations in GNAO1, Encoding a Gαo Subunit of Heterotrimeric G Proteins, Cause Epileptic EncephalopathyThe American Journal of Human Genetics, 2013
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networksBiochemical Journal, 2011
- Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOROncogene, 2011
- Molecular basis of a novel oncogenic mutation in GNAO1Oncogene, 2011
- Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)Biochemical Journal, 2010
- Diverse somatic mutation patterns and pathway alterations in human cancersNature, 2010
- Gnao1 (GαO protein) is a likely genetic contributor to variation in physical dependence on opioids in miceNeuroscience, 2009
- mTOR—What Does It Do?Transplantation Proceedings, 2008